Show simple item record

dc.contributor.authorOzyurt Kose, Selen
dc.contributor.authorNazli, Ezgi
dc.contributor.authorTutkavul, Kemal
dc.contributor.authorGilhus, Nils Erik
dc.date.accessioned2024-02-12T13:39:06Z
dc.date.available2024-02-12T13:39:06Z
dc.date.created2023-09-22T12:10:56Z
dc.date.issued2023
dc.identifier.issn1664-2295
dc.identifier.urihttps://hdl.handle.net/11250/3117041
dc.description.abstractMyasthenia gravis (MG) is a disorder of the neuromuscular junction that can deteriorate into myasthenic crisis, involving weakness of bulbar and respiratory muscles. In this study, we describe the clinical manifestations of myasthenic crisis, identify risk factors, and examine treatments and outcomes. All 95 patients with generalized MG treated at our center during the last 10 years were included in this retrospective study. We collected data from the patients' records, including clinical follow-ups, muscle antibodies, thymic status, and treatments. The characteristics of patients who did and did not experience myasthenic crisis were compared. Features of all myasthenic crises were also assessed. Twelve patients (13%) developed myasthenic crisis during the observation period. Men were more often affected at older ages. Seven patients experienced multiple myasthenic crises. Thymoma increased the risk of a crisis, whereas thymic hyperplasia decreased the risk. Myasthenic crises were more common in the summer months. No patients died during a myasthenic crisis. Risk factors for myasthenic crisis were thymoma, older age, MuSK antibodies, and previous crises. Individualized and active immunosuppressive treatment and optimal intensive care during crises provide a good outcome for patients with generalized MG.en_US
dc.language.isoengen_US
dc.publisherFrontiersen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleOccurrence and severity of myasthenic crisis in an unselected Turkish cohort of patients with myasthenia gravisen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2023 The Author(s)en_US
dc.source.articlenumber1201451en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.3389/fneur.2023.1201451
dc.identifier.cristin2177888
dc.source.journalFrontiers in Neurologyen_US
dc.identifier.citationFrontiers in Neurology. 2023, 14, 1201451.en_US
dc.source.volume14en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal